PO-1184 Pathological response after neoadjuvant chemotherapy versus chemoradiotherapy in stage III NSCLC. (August 2021) - Muñoz Guglielmetti, D.; Sánchez, D.; Reyes, R.; Boada, M.; Mases, J.; Mollà, M.; Casas, F.